ARTICLE | Clinical News
Rikelta brivaracetam: Phase III data
May 19, 2008 7:00 AM UTC
In a double-blind, placebo-controlled, international Phase III trial in about 56 patients, Rikelta missed the primary endpoint of symptom relief of action myoclonus. ...